Literature DB >> 20944002

An intrinsic mechanism predisposes Foxp3-expressing regulatory T cells to Th2 conversion in vivo.

Yunqi Wang1, Abdallah Souabni, Richard A Flavell, Yisong Y Wan.   

Abstract

Naturally occurring regulatory T (nTreg) cells express Foxp3 and were originally discovered as immune suppressors critical for self-tolerance and immune homeostasis. Through yet-to-be-defined mechanisms, nTreg cells were recently shown to convert into proinflammatory cells. Particularly, attenuation of Foxp3 expression led to Th2 conversion of nTreg cells in vivo. In this paper, we demonstrated an nTreg-specific mechanism controlling their Th2 conversion. We found that wild-type nTreg cells expressing reduced levels of Foxp3 but not those expressing no Foxp3 produced the Th2 cytokine IL-4. Intriguingly, IL-4 production by converted nTreg cells is required for Th2 differentiation of coexisting naive CD4 T cells in vivo, suggesting that Th2 conversion of nTreg cells might be critical for directing Th2 immune responses. Th2 conversion of nTreg cells was not due to their inability to become Th1 cells, because IFN-γ was produced by Foxp3-low-expressing cells when IL-4/STAT-6 signaling was abrogated. Surprisingly, however, unlike naive CD4 T cells whose IL-4 production is dependent on STAT-6, Foxp3-low-expressing cells generated IL-4 independent of STAT-6, indicating an intrinsic mechanism that favors nTreg-to-Th2 differentiation. Indeed, compared with naive CD4 T cells, nTreg expressed elevated levels of GATA-3 independent of STAT-6. And GATA-3 was required for nTreg-to-Th2 conversion. Foxp3 may account for this GATA-3 upregulation in nTreg cells, because ectopic expression of Foxp3 preferentially promoted GATA-3 but not T-bet expression. Thus, we have identified an intrinsic mechanism that imposes a Th2/Th1 imbalance and predisposes Foxp3-expressing cells to IL-4 production independent of STAT-6 signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944002      PMCID: PMC2974034          DOI: 10.4049/jimmunol.1001255

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival.

Authors:  P P Lee; D R Fitzpatrick; C Beard; H K Jessup; S Lehar; K W Makar; M Pérez-Melgosa; M T Sweetser; M S Schlissel; S Nguyen; S R Cherry; J H Tsai; S M Tucker; W M Weaver; A Kelso; R Jaenisch; C B Wilson
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

3.  Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter.

Authors:  M Mohrs; K Shinkai; K Mohrs; R M Locksley
Journal:  Immunity       Date:  2001-08       Impact factor: 31.745

Review 4.  Regulatory T cells in autoimmmunity*.

Authors:  E M Shevach
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

5.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

6.  Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.

Authors:  D Jankovic; M C Kullberg; N Noben-Trauth; P Caspar; W E Paul; A Sher
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

Review 7.  New insights into the differentiation and function of T follicular helper cells.

Authors:  Cecile King
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

8.  Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells.

Authors:  H Kurata; H J Lee; A O'Garra; N Arai
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

9.  Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma.

Authors:  Kate Blease; Jane M Schuh; Claudia Jakubzick; Nicholas W Lukacs; Steven L Kunkel; Bharat H Joshi; Raj K Puri; Mark H Kaplan; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

10.  A LAT mutation that inhibits T cell development yet induces lymphoproliferation.

Authors:  Connie L Sommers; Cheung-Seog Park; Jan Lee; Chiguang Feng; Claudette L Fuller; Alexander Grinberg; Jay A Hildebrand; Emanuela Lacaná; Rashmi K Menon; Elizabeth W Shores; Lawrence E Samelson; Paul E Love
Journal:  Science       Date:  2002-06-14       Impact factor: 47.728

View more
  49 in total

1.  TGFβ receptor mutations impose a strong predisposition for human allergic disease.

Authors:  Pamela A Frischmeyer-Guerrerio; Anthony L Guerrerio; Gretchen Oswald; Kristin Chichester; Loretha Myers; Marc K Halushka; Maria Oliva-Hemker; Robert A Wood; Harry C Dietz
Journal:  Sci Transl Med       Date:  2013-07-24       Impact factor: 17.956

2.  Itch expression by Treg cells controls Th2 inflammatory responses.

Authors:  Hyung-seung Jin; Yoon Park; Chris Elly; Yun-Cai Liu
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

3.  The transcriptional repressor Bcl6 controls the stability of regulatory T cells by intrinsic and extrinsic pathways.

Authors:  Deepali V Sawant; Hao Wu; Weiguo Yao; Sarita Sehra; Mark H Kaplan; Alexander L Dent
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

4.  Protein phosphatase 2A catalytic subunit α plays a MyD88-dependent, central role in the gene-specific regulation of endotoxin tolerance.

Authors:  Ling Xie; Cui Liu; Li Wang; Harsha P Gunawardena; Yanbao Yu; Ruyun Du; Debra J Taxman; Penggao Dai; Zhen Yan; Jing Yu; Stephen P Holly; Leslie V Parise; Yisong Y Wan; Jenny P Ting; Xian Chen
Journal:  Cell Rep       Date:  2013-02-21       Impact factor: 9.423

5.  Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function.

Authors:  Deepali V Sawant; Sarita Sehra; Evelyn T Nguyen; Rohit Jadhav; Kate Englert; Ryo Shinnakasu; Giao Hangoc; Hal E Broxmeyer; Toshinori Nakayama; Narayanan B Perumal; Mark H Kaplan; Alexander L Dent
Journal:  J Immunol       Date:  2012-10-10       Impact factor: 5.422

Review 6.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

7.  Directed differentiation of regulatory T cells from naive T cells and prevention of their inflammation-mediated instability using small molecules.

Authors:  M-H Haddadi; B Negahdari; E Hajizadeh-Saffar; M Khosravi-Maharlooei; M Basiri; H Dabiri; H Baharvand
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

Review 8.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 9.  The immune system's involvement in obesity-driven type 2 diabetes.

Authors:  Chengyi Jenny Shu; Christophe Benoist; Diane Mathis
Journal:  Semin Immunol       Date:  2013-01-18       Impact factor: 11.130

10.  An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos.

Authors:  Madhav D Sharma; Lei Huang; Jeong-Hyeon Choi; Eun-Joon Lee; James M Wilson; Henrique Lemos; Fan Pan; Bruce R Blazar; Drew M Pardoll; Andrew L Mellor; Huidong Shi; David H Munn
Journal:  Immunity       Date:  2013-05-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.